PFIZER LTD = RESULTS FOR Q 3 / E AUG 2010 = MUCH IMPROVED PERFORMANCE

PFIZER Limited

NSE Symbol   PFIZER

REVIEW OF RESULTS OF Q3

Pfizer Ltd has declared the results for the 3^rd Qtr ending 31.08.2010. It’s accounting year is Dec – Nov.

Net Sales for q/e Aug,2010 is Rs.225.61 Cr. At this rate, likely sales for Y/e Nov,2010 will be Rs.866.16 Cr  – compared to Rs.771.60 for previous year (Non-consolidated). For this purpose Q1+Q2+Q3 are taken and for Q4, same level as Q3 is assumed.

On the same logic, Net Profit for Q3 is Rs.42.48 Cr and likely profit for Y/e Nov,2010 is Rs.162.10 Cr – against Rs.137.18 Cr for previous year.

Basic EPS   for Q3 is Rs.14.24 (Rs.11.63 for Q2 + Rs.14.23 for Q1) and the likely EPS for the Y/E Nov,2010 is Rs.54.34 – compared to Rs.45.97 for preceding Year.

Current Market Price is Rs.1117.The PE ratio is around 20.6.

The company’s amalgamation was done with Du Chem Labs. But, these results are non-consolidated results only. The results are evidently much better than the results of Y/e Nov,2009 and reflect considerable progress over the previous year.

RESULTS IN FIGURES:

PFIZER	2010 Aug	2010 May	2010 Feb	Q1+Q2+ Q3 +(Q3 for Q4)	DEC08-NOV09
Net Sales	22561	21233	20261	86616	77160
Other Operating Income	1109	1112	494	3824	2437
SIT & WIP	-1517	-1234	1156	-3112	961
Raw Materials	6501	5720	4022	22744	19867
Purchase of Traded Goods	2042	2932	2604	9620	7906
Employees Cost	4616	4973	2736	16941	12388
Depreciation	249	222	229	949	829
Other Expenditure	6796	6333	5064	24989	22651
Total Expenditure	18687	18946	15811	72131	64602
Profit from Operations	4983	3399	4944	18309	14995
Other Income	1591	2148	1548	6878	7101
Profit A I BB EI	6574	5547	6492	25187	22096
Exceptional Items	147	124	-	271	1092
Profit before tax	6427	5423	6492	24769	21004
Tax expense	2179	1954	2247	8559	7286
Net Profit after tax	4248	3469	4245	16210	13718
Net Profit	4248	3469	4245	16210	13718
Dividend (%)	-	-	-		125
Face Value .Rs	10	10	10	10	10
Paid Up Equity	2984	2984	2984	2984	2984
Basic EPS	14.24	11.63	14.23	54.34	45.97
Public holding (%)	29.25	29.25	29.25	29.25	29.25

ANNOUNCEMENTS

TO THE EXCHANGE

06-10-2010        Pfizer Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-AUG-2010 as follows: Net Sales of Rs. 22561 lacs for quarter ending on 31-AUG-2010 against Rs. 20484 lacs for the quarter ending on 31-AUG-2009. Net Profit / (Loss) of Rs. 4248 lacs for the quarter ending on 31-AUG-2010 against Rs. 4115 lacs for the quarter ending on 31-AUG-2009.      -

12-07-2010        Pfizer Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAY-2010 as follows: Net Sales of Rs. 21233 lacs for quarter ending on 31-MAY-2010 against Rs. 18585 lacs for the quarter ending on 31-MAY-2009. Net Profit / (Loss) of Rs. 3469 lacs for the quarter ending on 31-MAY-2010 against Rs. 3129 lacs for the quarter ending on 31-MAY-2009.

19-05-2010        News Verification : The media had reports that Pfizer Limited may buy a controlling stake in Piramal Healthcare Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Pfizer Limited has vide its letter inter-alia stated," We wish to inform you that as a policy we do not comment on market rumours and speculations."

25-02-2010        Pfizer Ltd. has informed the Exchange that the Board of Directors at its meeting held on February 25, 2010, recommended a Dividend of Rs. 12.50 per Equity Share of Rs.10/- each (125%) for the financial year ended November 30, 2009. 

25-02-2010        Pfizer Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 30-NOV-2009 as follows: Net Sales of Rs. 77227 lacs for year ending on 30-NOV-2009 against Rs. 68170 lacs for the year ending on 30-NOV-2008. Net Profit / (Loss) of Rs. 13712 lacs for the year ending on 30-NOV-2009 against Rs. 29958 lacs for the year ending on 30-NOV-2008.

BOARD MEETINGS

19-03-2010        The Company proposes to reconsider the audited Financial Results of the merged entity i.e. Pfizer Ltd. and Duchem Laboratories Ltd. A meeting of the Board of Directors of Pfizer Ltd. would be held on March 19, 2010, to reconsider and approve the Annual Financial Results of the merged entity with a view to give effect to the Court order.

*  *  *    E N D   *  *  *

AUTO SECTOR SALES UPTO SEP 2010 = UPDATE DT 04 10 2010 = Maruti,TATA Motors, M&M, Bajaj Auto, Hero Honda, TVS Motors, A shok Leyland

AUTO SECTOR SALES

UPTO SEP 2010

UPDATE DATED 04 10 2010

MARUTI,TATA MOTORS, M&M, BAJAJ AUTO, HERO HONDA, TVS MOTORS, ASHOK LEYLAND

MARUTI SUZUKI :

Maruti Suzuki has sold a total of 1,08,006 vehicles in September 2010. This includes 12,858 units for export.

This is the highest ever Total monthly sales by the company. Previous highest was 1,04,971 units in August 2010.

The company had sold a total of 83,306 vehicles in September 2009.

September 2010 is also the fourth time that company's monthly sales crossed 1 lakh mark. With these record numbers, the company crossed half a million sales mark in the first six months of a fiscal.

Maruti Suzuki's volume in the domestic market grew by 32.9 per cent. In the A2 segment, sales grew by 31.3 per cent while in A3 segment sales were 43.2 per cent higher, as compared to sales in September 2009. The sales growth in the C segment was 66.6 per cent over September 2009. The sales growth in B segment was 17.7% over September 2009.

TATA MOTORS

Tata Motors’ total sales (including exports) of Tata commercial and passenger vehicles in September 2010 were 64,668 vehicles, a growth of 23% over 52,513 vehicles sold in September 2009. The company’s domestic sales of Tata commercial and passenger vehicles for September 2010 were 59,611 nos., a 20% growth over 49,650 nos. sold in September last year.

Cumulative sales (including exports) for the company for the fiscal are 380,113 nos., a growth of 39% over 273,491 nos. sold last year.

MAHINDRA & MAHINDRA

 M&M has reported its highest ever monthly sales at 35,177 units in September 2010,  up  23.71 % over the same month last year.

Total sales of utility vehicles which includes Scorpio, Xylo, Bolero and Pick Ups stood at16,537 units. The sales of Logan, has gone up by a whopping 1000 units, a rise of 96%, compared to the same month a year ago.

Sales of three-wheelers and Gio and Maxximo mini-trucks during September jumped by 40.90 per cent to 6,005 units from 4,262 units during the same month last year.

Mahindra Navistar light commercial vehicle sales also jumped by 40.90 percent to 6005 units compared to 4262 units during the same period last year.

Exports also jumped by 86% to 1,311 units compared to 703 units during September 2009.

The company has also entered into 2 wheeler segment already with scooters and is now introducing Motor cycles.

BAJAJ AUTO

Bajaj Auto Ltd has reported a 26% growth in motorcycle sales at 3,14,515 units in September 2010, against 2,49.133 motorcycles in September last year. The company had achieved the highest ever motorcycle sales and Pulsar sales during the month. The Discover model launched in 2009 July has crossed the one million sales mark. Commercial vehicle sales were up 23% to 38,254 units. The total sales during September was 3,52,769 units compared to 2,80,916 in the same month last year. Exports was up 26% to 1,01,960 units from 80,681 last year same time.

Motorcycle sales from April 2010 to September” 10 was up 58% to 17,11,863 units while commercial vehicle sales was up 46% to 2,16,994 units. Total sales till September this year was up 56% to 19,28,884 units up from 12,34,389 units last year same period. Exports during this time has gone up to 6,31,231 units which is a 57% growth over last year. Exports are on course to exceed one million units this year, it said.

HERO HONDA

 Hero Honda sold 4,33,641 units during September registering a growth of 8%. In September last year, the company sold 401,290 units. This is the fifth consecutive month of 4-lakh plus sales for the company. The company is also introducing new models in the festive season.

TVS MOTORS

TVS Motors total sales stood at 188,005 units in September 2010 against 143,753 units in September 2009.

Its total two-wheeler sales surged 30% to 1,84,783 units in September 2010 over September 2009. The company's domestic sales rose 25% to 1,65,418 units and exports soared 89% to 19,365 units in September 2010 over September 2009.

The company's three-wheeler sales jumped 169% to 3,222 units in September 2010 September 2009.

ASHOK LEYLAND

Ashok Leyland has reported a 90.22 per cent jump in commercial vehicle sales to 10,363 units in September.

The company had sold 54,48 units in the same month last year.

Domestic sales stood at 9,513 units in September as against 4,809 units in the same month last year, up 97.82 per cent.

Exports increased by 33.02 per cent to 850 units during the month, compared to 639 units in the year-ago period.
The company also reported a 99.08 per cent increase in total domestic sales of medium and heavy commercial vehicles to 9,474 units from 4,759 units in the same month last year.

SUMMARY :

It can be seen from the Sales figures of major automobile manufacturers up to September,2010, that the Auto Industry is in the PINK OF HEALTH, with both domestic sales and export sales rising for almost all manufacturers.

All of them are recording the Highest ever sales month after month.

Other directly connected sectors like steel, auto ancillaries etc are also therefore bound to do well in this scenario.

This shows the robustness of the Indian economy and is bound to reflect in the sales and profitability of most other sectors as well.

* * *   E N D   * * *